The best choice in SFA procedures depending on multiple factors (Live Session)

Program

Cases in box: Clinical Data

• Case in box n°1: Past Medical History
  • 56 years old
  • MEDICAL: HTA, Dyslipidemia, Smoking: 40 PY (activ), Sleep apnea, Chronic lumbar pain
  • SURGICAL: none
  • Treatment: Statine, Clopidogrel, ACEI, Ca Antagonists
    
    

• Case in box n°2: Past Medical History
  • 66 years old
  • MEDICAL: HTA, Dyslipidemia, Smoking history: 60 PY (↕ 2011), COPD
  • SURGICAL: Right ilio-femoral bypass grafting in 2012, CABG x3 in 2011, Hiatal hernia, Bilat, Vein stripping
  • Treatment: Statine, Clopidogrel, Bisoprolol
    
    

• Case in box n°3: Past Medical History
  • 66 years old
  • MEDICAL: HTA, Smoking history (↕ 2010), Dyslipidimia, Lupus
  • SURGICAL: Right Com. Fem stenting in 2009, Left Ext. Iliac stenting in 2014, Ilio-fem endarteriectomy in 2004, Total hip replacement
  • Treatment: Clopidogrel, ACEI, Statine
    
    
     

Educational objectives

• Discuss current trends and approaches to the treatment of SFA lesions with the use of DES and DCB in long lesions, in terms of patient’s outcomes.
• Learn and observe a step-by-step complex procedure with technical and strategical tips & tricks.
• How to choose your strategy depending on clinical, anatomical and cost efficiency criteria.
• Demonstrate advanced techniques and new drug eluting technologies in the treatment of peripheral artery disease.
• Provide platform for discussion and mutual learning with your experts.

Audience

• Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Interventional Angiologists and Interventional Cardiologists).
• Referring physicians of patients with peripheral artery disease.